NUWE

Nuwellis, Inc.

$5.24

6.07%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Source: Yahoo Finance
AI summary

Price & performance

1M-22.5%
3M-69.8%
YTD-99.1%
1Y-99.5%
52-week range—
Beta1.69
Full chart and returns against a benchmark

Q-Score

7/ 100

Quality against peers; 50 is the peer median.

Growth20
Risk12
Performance10
Valuation20
Profitability46
Leverage12
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$8.3M-5.4%
Net income-$17.5M
Net margin-211.9%-84.1 pts
Historical fundamentals

Red flags in filings

2active red flags
Going-concern doubtMar 11, 2026
Material weakness in controlsMar 11, 2026
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Largest customer14%
Regions, segments, customers and suppliers

Valuation

NUWEIndustryP/E—29.61P/S0.243.49EV/EBITDA—18.38P/B—3.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 12next report, before the open
EPS estimate—
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate